Tazarotene 45802-0436-01
- Manufacturer
- Padagis Israel Pharmaceuticals Ltd
- Dosage Form
- Gel
- Route
- Topical
- Product Type
- Human Prescription Drug
- Marketing Start
- June 5, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA213079
Need to source Tazarotene? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tazarotene | .5 mg/g |
Drug Class
Retinoid [EPC]Retinoid [EPC]Retinoids [CS]
Selected Package
45802-0436-01Selected1 TUBE in 1 CARTON (45802-436-01) / 100 g in 1 TUBE
Other packages for this product(1)
1 TUBE in 1 CARTON (45802-436-94) / 30 g in 1 TUBE